Fundraising FoxRV Invest GmbH
Venture capitalRavensburg · Seed–Series A · 8 people tracked
Find your way into RV Invest GmbH
Sign up to find every way you can get introduced to RV Invest GmbH
- Your email: who you already know at RV Invest GmbH, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the RV Invest GmbH team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
RV Invest is a venture capital fund dedicated to backing innovations that improve patients' lives. The firm invests early and works closely with founders and researchers to bring outstanding scientific ideas to market. Its focus is on highly differentiated technical solutions in biotechnology and medicine that have the potential to become future standards of care. The portfolio spans areas such as cell and gene therapy, RNA-guided technologies, radiopharmaceuticals, epigenetic medicine, rare disease treatments, and cancer immunotherapy, reflecting a strong orientation toward cutting-edge therapeutic platforms addressing high unmet medical needs.
Source: firm website, verified Oct 2, 2026.
Team · 8 people
from the firm's websiteWhat they invest in
from 8 of 12 portfolio companiesBiotech ×8Healthtech ×7Medical Devices ×5AI & Machine Learning ×4Deep Tech ×2Longevity ×2Digital Health ×1
HQs:United States×5Germany×1Sweden×1
Investments · 12 tracked
founders shown can be your intro path
Alesta Therapeutics develops therapies for rare diseases, with research focused on genetic diseases and oncology.
BiotechHealthtech
Ilan Ganot(CEO)inBenit Maru(CMO)Matthias Van Woensel(CSO)in
Co-investorsDroia VenturesFrazier Life SciencesNovartis Venture FundFrazier Healthcare PartnersMPM BioImpactRTW Investments L.P.+1 more
Arda develops therapeutics using single-cell computational biology to target and eliminate pathogenic cells in chronic diseases.
AI & Machine LearningBiotechDigital HealthLongevityMedical DevicesAustin, US
Adam Freund(Founder & Chief Executive Officer)inRemi-Martin Laberge(Founder and Chief Technology Officer)in
BoardVineeta Agarwala(Director)in
Co-investorsage1Alumni VenturesAndreessen HorowitzGV (Google Ventures)LifelinkOlima Ventures+7 more
Asgard Therapeutics develops direct cell reprogramming technologies that convert cancer cells into dendritic cells to restore anti-cancer immune responses.
AI & Machine LearningBiotechHealthtechMedical DevicesLund, SE
Cristiana Pires(Co-founder and CEO)inFábio Rosa(Co-founder and VP of Research)inFilipe Pereira(Co-founder and Head of Innovation)in
Co-investorsIndustrifondenLU InnovationNovo HoldingsBoehringer Ingelheim Venture Fund
Diagonal Therapeutics develops multi-specific clustering antibody therapeutics that bind multiple cell-surface receptors to activate or inhibit dysregulated signaling pathways underlying chronic diseases.
AI & Machine LearningBiotechHealthtechWatertown, US
Co-investorsAtlas VentureEcoR1 CapitalFrazier Life SciencesRA CapitalSanofi VenturesViking Global
Immusoft develops a cell therapy platform called Immune System Programming (ISP) that engineers a patient's B cells into plasma cells that produce therapeutic proteins after being infused back into the patient.
BiotechDeep TechHealthtechSeattle, US
Matthew Scholz(Founder)inSean Ainsworth(Chief Executive Officer)inRobert Sikorski(Chief Medical Officer)Rob Hayes(Chief Scientific Officer)inScott McIvor(Chief Development Officer)Eric Garcia(Executive Officer)in
Co-investorsBioRock VenturesBoston Harbor AngelsBreakout VenturesEQx FundInvariantes FundMichigan Capital Network+6 more
ITM is a vertically integrated biotechnology company specializing in precision oncology through radioisotope production and radiopharmaceutical development, with clinical programs advanced through subsidiary Lumara Bio.
BiotechHealthtechMedical Devices
Alexander Pironi(Executive Vice President, Global Head of Radioisotopes)inDr. Konstantin Zhernosekov(Chief Scientific Officer & Managing Director ITM Medical Isotopes & ITM Oncologics)
Co-investorsCapmontNextech Invest
Tune Therapeutics develops a therapeutic platform targeting the epigenome to treat complex diseases and regenerative medicine applications.
BiotechDeep TechHealthtechLongevityMedical DevicesDurham and Seattle, US
Akira Matsuno(Executive Officer)inDerek Jantz(Executive Officer)inCharles Gersbach(Director)inJohn McHutchison(CEO, Chairman of the Board)inDan McHugh(Executive Officer, Director)inBlythe Sather(Executive Officer)in
Co-investorsDuke Capital PartnersHatteras Venture PartnersMission BiocapitalNew Enterprise Associates (NEA)Pappas CapitalSaisei Ventures+1 more
Valink Therapeutics develops bispecific antibody-drug conjugates (ADCs) for therapeutic applications, combining high-throughput discovery, antibody engineering, and medicinal chemistry capabilities.
AI & Machine LearningBiotechHealthtechMedical DevicesBoston, US
Arne Scheu(Co-Founder & CEO)inIrsyad Khairil(Co-Founder & CTO)in
Co-investorsHoxton VenturesLongeVCMetaplanetOxonian VenturesP53 InvestSynBioVen+9 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Alesta TherapeuticsDiagonal TherapeuticsITM Isotope Technologies Munich SE
Portfolio news
latest coverage across their companiesImmusoft · immusoft.com · Mar 30, 2026
Valink Therapeutics · finsmes.com · Oct 20, 2025
ITM · itm-radiopharma.com · May 27, 2025
Frequently asked questions
- How many investments has RV Invest GmbH made?
- RV Invest GmbH has 12 tracked investments.
- What stage does RV Invest GmbH invest at?
- RV Invest GmbH invests at the Seed, Series A stages.
- What sectors does RV Invest GmbH focus on?
- RV Invest GmbH focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is RV Invest GmbH located?
- RV Invest GmbH is headquartered in Ravensburg, DE.